Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

THE GEORGE INSTITUTE

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Phase 4

Completed

Conditions: COVID-19
Coronavirus Disease 2019

Interventions: Drug: Angiotensin Receptor Blockers
Other: Placebo

First Posted Date: 2020-05-19

Last Posted Date: 2022-03-17

Lead Sponsor: The George Institute

Target Recruit Count: 787

Registration Number: NCT04394117

Locations: 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺
Canterbury Hospital, Campsie, New South Wales, Australia
🇦🇺
The Sutherland Hospital, Caringbah, New South Wales, Australia

and more 19 locations

Global Kidney Patient Trials Network

Recruiting

Conditions: Kidney Diseases

First Posted Date: 2020-05-15

Last Posted Date: 2023-01-18

Lead Sponsor: The George Institute

Target Recruit Count: 6000

Registration Number: NCT04389827

Locations: 🇦🇺
The George Institute, Sydney, New South Wales, Australia

Essential Acute Stroke Care in Low Resource Settings: a Pilot studY

Not Applicable

Not yet recruiting

Conditions: Acute Stroke

Interventions: Other: Acute stroke care Intervention arm

First Posted Date: 2019-11-08

Last Posted Date: 2025-03-06

Lead Sponsor: The George Institute

Target Recruit Count: 300

Registration Number: NCT04157231

Locations: 🇳🇬
Murtala Muhammad Specialist Hospital, Kano, Kano State, Nigeria
🇳🇬
Federal Medical Centre, Lokoja, Kogi State, Nigeria
🇵🇪
Hospital de Apoyo II-2 Sullana, Piura, Peru

and more 1 locations

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

Phase 3

Recruiting

Conditions: Dialysis-dependent Kidney Failure
Cardiovascular Disease
Chronic Kidney Diseases

Interventions: Other: Placebo
Drug: Rivaroxaban 2.5 Mg Oral Tablet

First Posted Date: 2019-05-31

Last Posted Date: 2023-11-28

Lead Sponsor: The George Institute

Target Recruit Count: 2000

Registration Number: NCT03969953

Locations: 🇦🇺
Canberra Hospital, Garran, Australian Capital Territory, Australia
🇦🇺
Concord Repatriation General Hospital, Concord, New South Wales, Australia
🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia

and more 79 locations

Preventing Adverse Cardiac Events in COPD

Phase 3

Completed

Conditions: Cardiovascular Diseases
Chronic Obstructive Pulmonary Disease

Interventions: Drug: Placebo Oral Tablet
Drug: Bisoprolol

First Posted Date: 2019-04-17

Last Posted Date: 2025-05-16

Lead Sponsor: The George Institute

Target Recruit Count: 280

Registration Number: NCT03917914

Locations: 🇮🇳
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
🇮🇳
St John's Medical College Hospital, Bangalore, India
🇮🇳
Postgraduate Institute of Medical Education and Research, Chandigarh, India

and more 21 locations

The Effects on Blood Pressure of Salt Substitute Among Adults With Hypertension in India

Not Applicable

Completed

Conditions: Blood Pressure

Interventions: Behavioral: Dietary sodium reduction

First Posted Date: 2019-04-10

Last Posted Date: 2021-04-01

Lead Sponsor: The George Institute

Target Recruit Count: 502

Registration Number: NCT03909659

Locations: 🇮🇳
The George Institute for Glaobal Health India, New Delhi, India

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study

Phase 3

Terminated

Conditions: Cognitive Decline
Intracerebral Hemorrhage
Dementia, Vascular
Cerebral Small Vessel Diseases
Hypertension
Stroke Hemorrhagic

Interventions: Drug: Placebo oral capsule
Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg

First Posted Date: 2018-12-24

Last Posted Date: 2021-04-01

Lead Sponsor: The George Institute

Target Recruit Count: 1

Registration Number: NCT03785067

Locations: 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

and more 1 locations

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study

Not Applicable

Terminated

Conditions: Intracerebral Hemorrhage
Stroke
Cerebral Small Vessel Diseases
Vascular Dementia
Hypertension

Interventions: Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg
Drug: Placebo oral capsule

First Posted Date: 2018-12-21

Last Posted Date: 2021-05-25

Lead Sponsor: The George Institute

Target Recruit Count: 4

Registration Number: NCT03783754

Locations: 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺
Sunshine Coast University Hospital, Birtinya, Queensland, Australia
🇦🇺
Royal Melbourne Hospital, Melbourne, Victoria, Australia

Lifestyle Intervention IN Gestational Diabetes (LIVING)

Not Applicable

Completed

Conditions: Gestational Diabetes Mellitus in Pregnancy

Interventions: Behavioral: Life style Intervention

First Posted Date: 2017-10-10

Last Posted Date: 2021-03-23

Lead Sponsor: The George Institute

Target Recruit Count: 1612

Registration Number: NCT03305939

Locations: 🇧🇩
Marie Stopes Clinic, Dhaka, Bangladesh
🇧🇩
Azimpur Matenity Clinic, Dhaka, Bangladesh
🇧🇩
BIRDEM (Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders), Dhaka, Bangladesh

and more 17 locations

Beta-Lactam InfusioN Group Study

Not Applicable

Completed

Conditions: Sepsis

Interventions: Other: Intermittent infusion
Other: Continuous infusion

First Posted Date: 2017-07-11

Last Posted Date: 2023-12-12

Lead Sponsor: The George Institute

Target Recruit Count: 7203

Registration Number: NCT03213990

Locations: 🇦🇺
Bankstown Hospital, Bankstown, New South Wales, Australia
🇦🇺
Blacktown Hospital, Blacktown, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

and more 100 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy